Isabelle H. Boucot
Brentford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?
Journal: Chronic respiratory disease
Published: October 06, 2023
Correction to: New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management.
Journal: Advances in therapy
Published: June 18, 2022
Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD.
Journal: Respiratory medicine
Published: February 23, 2022
New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management.
Journal: Advances in therapy
Published: December 15, 2021
Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic.
Journal: Advances in therapy
Published: November 22, 2021
Insights from the AUSTRI study on reliever use before and after asthma exacerbations.
Journal: The journal of allergy and clinical immunology. In practice
Published: November 15, 2021
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model.
Journal: International journal of chronic obstructive pulmonary disease
Published: July 29, 2021
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial.
Journal: Respiratory research
Published: May 13, 2021
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX Trial.
Journal: Advances in therapy
Published: May 03, 2021
The impact of fluticasone furoate/vilanterol on healthcare resource utilisation in the Salford Lung Study in chronic obstructive pulmonary disease.
Journal: Therapeutic advances in respiratory disease
Published: March 30, 2021
Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial.
Journal: International journal of chronic obstructive pulmonary disease
Published: February 15, 2021
Last Updated: 09/26/2026